Listar DMed-Artículos, capítulos... por autor "3ee9262c-3560-46bb-91aa-c834664bb959"

Mostrando ítems 1-2 de 2

    • Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19 

      Roy Vallejo, Emilia; Sánchez Purificación, Aquilino; Torres‑Peña, J.D.; Sánchez Moreno, Beatriz; Arnalich-Fernández, Francisco; García Blanco, María José; López-Miranda, José; Romero-Cabrera, Juan Luis; Herrero Gil, Carmen Rosario; Bascunana, José; Rubio-Rivas, Manuel; Pintos Otero, Sara; Martínez Sempere, Verónica; Ballano Rodríguez-Solís, Jesús; Gil Sánchez, Ricardo; Luque del Pino, Jairo; González Noya, Amara; Navas-Alcántara, María Sierra; Cortés Rodríguez, Begoña; Alcalá, José Nicolás; Suárez-Lombraña, Ana; Soler, Jorge Andrés; Gómez-Huelgas, Ricardo; Casas-Rojo, José Manuel; Millán Núñez-Cortés, Jesús; SEMI‐COVID‐19 Network (MDPI, 2021)
      Our main aim was to describe the effect on the severity of ACEI (angiotensin-converting enzyme inhibitor) and ARB (angiotensin II receptor blocker) during COVID-19 hospitalization. A retrospective, observational, multicenter ...

    • Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study 

      Alcalá Díaz, Juan Francisco; Limia-Pérez, Laura; Gómez-Huelgas, Ricardo; Martín-Escalante, María D.; Cortés Rodríguez, Begoña; Zambrana-García, José L.; Entrenas-Castillo, Marta; Pérez-Caballero, Ana I.; López-Carmona, María D.; García-Alegría, Javier; Lozano Rodríguez-Mancheño, Aquiles; Arenas-de Larriva, María del Sol; Pérez-Belmonte, Luis M.; Jungreis, Irwin; Bouillon, Roger; Quesada Gómez, José Manuel; López-Miranda, José (MDPI, 2021)
      Context. Calcifediol has been proposed as a potential treatment for COVID-19 patients. Objective: To compare the administration or not of oral calcifediol on mortality risk of patients hospitalized because of COVID-19. ...